JESSICA IVEY: Open Payments
NPI 1629796362 · HAZARD, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,200 in 56 payments from 26 companies in 2025. Trend: 2023 $1,064 · 2024 $864 · 2025 $1,200
Food & beverage: $1,200
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 9 | $160 |
| AstraZeneca Pharmaceuticals LP | 3 | $97 |
| Daiichi Sankyo Inc. | 4 | $89 |
| Novartis Pharmaceuticals Corporation | 4 | $87 |
| Regeneron Healthcare Solutions, Inc. | 3 | $77 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $77 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $72 |
| ABBVIE INC. | 3 | $67 |
| PROGENICS PHARMACEUTICALS, INC. | 2 | $48 |
| Incyte Corporation | 2 | $46 |
Products named: LIBTAYO, VENCLEXTA, KISQALI, TAGRISSO, FRUZAQLA, Nubeqa, PYLARIFY, Enhertu.
Industry payments across KY — which companies pay providers there.
